MarketInOut Stock Screener Log In | Sign Up

BriaCell Therapeutics Corp Wt

NASDAQ • Healthcare • Biotechnology • Quote as of 11/17/2026 16:00
BriaCell Therapeutics Corp Wt stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization33.45 mln
Earnings Date12/11/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

91 / 100
Top performer

ROE

-162
Deeply negative

ROA

-137
Deeply negative

Business Description

BriaCell Therapeutics Corp. is a Canadian cancer treatment company focused on creating new ways to help the immune system fight tumors. Its most advanced program, Bria-IMT, is currently in Phase 3 trials for late-stage breast cancer, while other treatments in development aim to target a broader range of cancer types. The company works with leading research partners, including a collaboration with MSK Accelerator and a licensing agreement with the University of Maryland Baltimore County, to bring its therapies to patients faster.

Key Fundamentals

EPS-6.97
ROE-162
ROIC-881
ROA-137
Interest Cover-1,210
EBITDA, mln-35.93
EV / EBITDA-0.54

Quote Details

Last 0.125
Change 0.0101 (8.79%)
Open 0.1015
Volume 143,502
Turnover 17,938
Average Volume 20,267

Financial Ratios

Leverage Ratio1.44
Current Ratio7.07
Price / Book0.06

Financial Strength

Piotroski F-Score 3 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.27% 57 / 100   
1 Month -20.13% 20 / 100   
2 Months 40.13% 98 / 100   
6 Months 39.82% 95 / 100   
1 Year -62.69% 14 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog